Literature DB >> 24722310

Neuroimaging features and predictors of outcome in eclamptic encephalopathy: a prospective observational study.

V Junewar1, R Verma2, P L Sankhwar3, R K Garg1, M K Singh1, H S Malhotra1, P K Sharma1, A Parihar4.   

Abstract

BACKGROUND AND
PURPOSE: Posterior reversible encephalopathy syndrome is associated with eclampsia. We assessed the distribution and nature of typical and atypical cranial MR imaging findings in these patients and their correlation with clinical and laboratory data and predictors of outcome.
MATERIALS AND METHODS: Forty-five clinically confirmed cases of eclampsia were included in this prospective observational study. Subjects with hemolysis, elevated liver enzymes, and low platelets syndrome (n = 9) and pre-existing neurologic conditions (1 with cerebral solitary cysticercus granuloma) were excluded. Patients underwent blood investigations and cranial MR imaging.
RESULTS: Twenty-seven patients had abnormal while 8 had normal MR imaging findings. Involvement of brain regions was as follows: frontal, 88.89%; temporal, 44.44%; parietal, 100%; occipital, 100%; deep gray matter, 29.63%; cerebellum, 22.22%; brain stem, 14.81%. Cytotoxic edema was present in 33.33% of cases; 66.67% of patients had mild posterior reversible encephalopathy syndrome; 25.92% had moderate posterior reversible encephalopathy syndrome; and 7.41% had severe posterior reversible encephalopathy syndrome. Abnormal neuroimaging findings were significantly associated with altered sensorium; visual disturbances; status epilepticus; and elevated serum creatinine, uric acid, and lactate dehydrogenase (P=.006, P=.018, P=.015, P=.019, P=.003, and P=.001, respectively). Serum creatinine, uric acid, and lactate dehydrogenase values and the presence of moderate or severe posterior reversible encephalopathy syndrome were significantly associated with mortality (P<.001, P<.001, P=.009, and P=.027, respectively).
CONCLUSIONS: Neuroimaging in eclampsia demonstrates a higher incidence of atypical distributions and cytotoxic edema than previously thought. Altered sensorium; visual disturbances; status epilepticus; and elevated serum uric acid, lactate dehydrogenase, and creatinine are associated with abnormal neuroimaging findings. Higher serum creatinine, uric acid, and lactate dehydrogenase levels and moderate and severe forms of posterior reversible encephalopathy syndrome are possible predictors of poor outcome.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2014        PMID: 24722310      PMCID: PMC7966267          DOI: 10.3174/ajnr.A3923

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  25 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  Association of degree and type of edema in posterior reversible encephalopathy syndrome with serum lactate dehydrogenase level: initial experience.

Authors:  Bo Gao; Feng-li Liu; Bin Zhao
Journal:  Eur J Radiol       Date:  2011-12-29       Impact factor: 3.528

3.  The reversible posterior cerebral edema syndrome.

Authors:  W P Dillon; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

4.  Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging.

Authors:  A M McKinney; B Sarikaya; C Gustafson; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

5.  ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

Authors: 
Journal:  Obstet Gynecol       Date:  2002-01       Impact factor: 7.661

6.  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

Review 7.  Posterior reversible encephalopathy syndrome: a review.

Authors:  Steven K Feske
Journal:  Semin Neurol       Date:  2011-05-17       Impact factor: 3.420

8.  The neurology of eclampsia : some observations.

Authors:  A Chakravarty; S D Chakrabarti
Journal:  Neurol India       Date:  2002-06       Impact factor: 2.117

9.  Magnesium sulphate regimens for women with eclampsia: messages from the Collaborative Eclampsia Trial.

Authors:  L Duley
Journal:  Br J Obstet Gynaecol       Date:  1996-02

Review 10.  The HELLP syndrome: clinical issues and management. A Review.

Authors:  Kjell Haram; Einar Svendsen; Ulrich Abildgaard
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-26       Impact factor: 3.007

View more
  14 in total

1.  Serum lactate dehydrogenase as a predictor of outcome in posterior reversible encephalopathy syndrome: imperative to unify.

Authors:  C Lv; B Gao
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

2.  Reply: To PMID 24722310.

Authors:  R Verma; V Junewar
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

Review 3.  Imaging neurological emergencies in pregnancy and puerperium.

Authors:  Matthew A Haber; Diego Nunez
Journal:  Emerg Radiol       Date:  2018-07-20

4.  The Clinical Outcome of Posterior Reversible Encephalopathy Syndrome.

Authors:  B Gao; A Lerner; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

5.  Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.

Authors:  Andrew D Schweitzer; Neal S Parikh; Gulce Askin; Ajay Nemade; John Lyo; Sasan Karimi; Anna Knobel; Babak B Navi; Robert J Young; Ajay Gupta
Journal:  Neuroradiology       Date:  2017-03-13       Impact factor: 2.804

6.  Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study.

Authors:  Eberhard Siebert; G Bohner; T Liebig; M Endres; T G Liman
Journal:  J Neurol       Date:  2016-11-04       Impact factor: 4.849

Review 7.  Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia.

Authors:  Omar C Logue; Eric M George; Gene L Bidwell
Journal:  Clin Sci (Lond)       Date:  2016-08-01       Impact factor: 6.124

8.  Maternal and Perinatal Outcome of Posterior Reversible Encephalopathy Syndrome (PRES) in Patients with Eclampsia at Tertiary Health Care Centre.

Authors:  Varsha Deshmukh; Vikas R Gangurde; Shrineewas Gadappa
Journal:  J Obstet Gynaecol India       Date:  2022-03-05

9.  Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis.

Authors:  Colin A Ellis; Andrew C McClelland; Suyash Mohan; Emory Kuo; Scott E Kasner; Cen Zhang; Pouya Khankhanian; Ramani Balu
Journal:  Neurohospitalist       Date:  2018-09-27

10.  Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis.

Authors:  Zheng Chen; Gang Zhang; Alexander Lerner; An-Hui Wang; Bo Gao; Jie Liu
Journal:  Quant Imaging Med Surg       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.